Spyre Therapeutics, Inc.: Form 8-K, filed Nov 18, 2024
Filed with the SEC on Nov 18, 2024 and accepted by EDGAR at Nov 18, 2024, 21:01 ET.
Items reported
- Item 4.02 Non-reliance on financial statements
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001636282-24-000105. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.